Compounded Tirzepatide Injections Recalled Over Sterility Concerns

Apothecary Pharma LLC has initiated a voluntary recall of specific lots of compounded tirzepatide injections, commonly used for weight loss, following an FDA warning. The recall stems from serious manufacturing deficiencies that could compromise product sterility, posing a moderate risk of temporary or reversible adverse health consequences. This Class II recall underscores the importance of stringent quality control in pharmaceutical compounding.